GT Biopharma, Inc.

Q2 2026 13F Holders

Symbol
GTBP
CUSIP
36254L308
Type
Equity
Class
COM
Num filers
59
Total reported value, excl. options
$1.02 M
Manager Report Date Value ($000) Shares Option Type